Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Krystal Biotech, Inc. - Common Stock (NQ:KRYS)

348.09 -3.17 (-0.90%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	222,382
Open	348.85
Bid (Size)	347.00 (200)
Ask (Size)	351.10 (80)
Prev. Close	351.26
Today's Range	340.18 - 353.12
52wk Range	136.73 - 382.54
Shares Outstanding	22,205,642
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Here’s How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years ↗

August 25, 2026

Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years by 32.97% on an annualized basis producing an average annual return of 44.08%. Currently, Krystal Biotech has a market...

Via Benzinga

Krystal Biotech (NASDAQ:KRYS) Clears Minervini Trend Template and High Growth Momentum Screen ↗

August 22, 2026

Via Chartmill

Performance

YTD	+41.0%	+41.0%
1 Month	+5.0%	+5.0%
3 Month	+11.4%	+11.4%
6 Month	+36.5%	+36.5%
1 Year	+146.5%	+146.5%

More News

Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More ↗

August 14, 2026

Via The Motley Fool

Krystal Biotech (KRYS) Q2 2026 Earnings Call Transcript ↗

August 10, 2026

Via The Motley Fool

Krystal Biotech (NASDAQ:KRYS) Slips After Q2 Revenue Miss Despite EPS Beat ↗

August 03, 2026

Via Chartmill

Krystal Biotech (NASDAQ:KRYS) Shows High-Growth Momentum With Perfect Minervini Trend Template Setup ↗

July 16, 2026

Via Chartmill

Krystal Biotech (NASDAQ:KRYS) Combines Perfect Trend Template with High-Growth Momentum ↗

May 09, 2026

Via Chartmill

Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It

August 11, 2026

From Biotech Insider

Via GlobeNewswire

If You Invested $1000 In Krystal Biotech Stock 5 Years Ago, You Would Have This Much Today ↗

August 10, 2026

Via Benzinga

Krystal Biotech Q2 Earnings Call Highlights ↗

August 03, 2026

Via MarketBeat

Krystal Biotech (NASDAQ:KRYS) Surges After Q1 Beat as VYJUVEK Revenue Hits $116.4M ↗

May 04, 2026

Via Chartmill

These 3 Healthcare Stocks Have Crushed the Market This Year. Here's Why There's More Upside Ahead ↗

July 24, 2026

Via The Motley Fool

Why Tutor Perini Stock Trounced the Market on Tuesday ↗

July 21, 2026

Via The Motley Fool

3 Soaring Stocks That May Have More Upside Ahead ↗

July 07, 2026

Via The Motley Fool

3 Biotech Firms With Major Potential Catalysts in the Coming Months ↗

June 21, 2026

Via MarketBeat

These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside Ahead ↗

June 18, 2026

Via The Motley Fool

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More ↗

May 30, 2026

Via The Motley Fool

Why This Tech Fund Made a $5.8 Million Bet on an AI Chip Stock Up Nearly 200% Post-IPO ↗

May 14, 2026

Via The Motley Fool

This AI Semiconductor Stock Beat the S&P 500 by 9 Points. A Fund Just Exited Completely ↗

May 14, 2026

Via The Motley Fool

Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position ↗

May 10, 2026

Via The Motley Fool

Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug ↗

May 10, 2026

Via The Motley Fool

Krystal (KRYS) Q1 2026 Earnings Transcript ↗

May 04, 2026

Via The Motley Fool

Krystal (KRYS) Q1 2025 Earnings Transcript ↗

May 04, 2026

Via The Motley Fool

Is Paymentus Stock a Buy After Palisades Investment Partners Increased Its Stake By $6 Million? ↗

May 01, 2026

Via The Motley Fool

Is Amprius Technologies Stock a Buy After Palisades Investment Partners Initiated a Position Worth $4.8 Million? ↗

May 01, 2026

Via The Motley Fool

Frequently Asked Questions

Is Krystal Biotech, Inc. - Common Stock publicly traded?

Yes, Krystal Biotech, Inc. - Common Stock is publicly traded.

What exchange does Krystal Biotech, Inc. - Common Stock trade on?

Krystal Biotech, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Krystal Biotech, Inc. - Common Stock?

The ticker symbol for Krystal Biotech, Inc. - Common Stock is KRYS on the Nasdaq Stock Market

What is the current price of Krystal Biotech, Inc. - Common Stock?

The current price of Krystal Biotech, Inc. - Common Stock is 348.09

When was Krystal Biotech, Inc. - Common Stock last traded?

The last trade of Krystal Biotech, Inc. - Common Stock was at 09/09/26 04:00 PM ET

What is the market capitalization of Krystal Biotech, Inc. - Common Stock?

The market capitalization of Krystal Biotech, Inc. - Common Stock is 7.73B

How many shares of Krystal Biotech, Inc. - Common Stock are outstanding?

Krystal Biotech, Inc. - Common Stock has 8B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.